AR and prostate carcinoma: Somatic mutations in the AR gene have been found to be particularly prevalent in CRPC, where its somatic mutation rate is about 16.8% (72/429) based on data from 429 prostate cancer patients in the Cancer Genome Atlas (TCGA) database.